|Acquired by||Anika Therapeutics|
|Terms||Cash and Stock|
|Phone||(+39) 049 8232523|
Fidia Advanced Biopolymers s.r.l. (FAB), Fidiaâ€™s subsidiary, was formed in 1992. It is an independent company operating in the advanced biomedical field.
The company utilizes its integrated R&D capabilities to develop devices of novel conception, which are designed to offer advanced solutions to specific clinical needs.
FAB research has produced HYAFF, hyaluronic acid in solid form, a totally biocompatible and biodegradable biomaterial, forerunner of a vast series of biopolymers used in diverse applications, the most sophisticated of which is Tissue Engineering.